JOURNAL ARTICLE

Mark Cuban's Online Pharmacy to Sell Blockbuster Blood Thinner Eliquis.

  • Published In: Bloomberg.com, 2026. P. N.PAG 1 of 3

  • Database: Business Source Ultimate 2 of 3

  • Authored By: Smith, Gerry 3 of 3

Abstract

The article focuses on Mark Cuban's low-cost online pharmacy, the Mark Cuban Cost Plus Drug Company, beginning to sell the blood thinner Eliquis starting next week. Eliquis, a widely prescribed oral anticoagulant developed by Bristol Myers Squibb Co. and Pfizer Inc., will be offered at $345 for a 30-day supply, matching prices on the drugmakers' patient support website. This move reflects a broader trend of pharmaceutical companies selling medications directly to consumers to increase accessibility and reduce costs by bypassing traditional pharmacy benefit managers. Cuban's company, launched in 2021, primarily offers generic drugs with transparent pricing through mail order. [Extracted from the article]

Additional Information

  • Source:Bloomberg.com. 2026/04, pN.PAG
  • Document Type:Article
  • Subject Area:Business and Management
  • Publication Date:2026
  • Accession Number:193260827
  • Copyright Statement:Copyright of Bloomberg.com is the property of Bloomberg, L.P. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.